Recombinant Human TIMP-4 (Sf 21-expressed) Protein, CF Summary
Details of Functionality
Measured by its ability to inhibit human MMP-2 cleavage of a fluorogenic peptide substrate Mca-PLGL-Dpa-AR-NH2 (Catalog # ES001). The IC50 value is approximately 2.5 nM, as measured under the described conditions.
Source
Spodoptera frugiperda, Sf 21 (baculovirus)-derived human TIMP-4 protein Cys30-Pro224
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Note
<1.0 EU per 1 μg of the protein by the LAL method.
Applications/Dilutions
Dilutions
Inhibition Activity
Theoretical MW
22 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
SDS-PAGE
23 kDa, reducing conditions
Publications
Read Publications using 974-TSF in the following applications:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
6 months from date of receipt, -20 to -70 °C as supplied.
3 months, -20 to -70 °C under sterile conditions after reconstitution.
Buffer
Lyophilized from a 0.2 μm filtered solution in Tris and NaCl.
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Reconstitution Instructions
Reconstitute at 200 μg/mL in sterile, deionized water.
Assay Procedure
Assay Buffer: 50 mM Tris, 10 mM CaCl2, 150 mM NaCl, 0.05% (w/v) Brij-35, pH 7.5 (TCNB)
Recombinant human TIMP-4 (rhTIMP-4) (Catalog # 974-TSF)
Recombinant Human MMP‑2 (rhMMP‑2) (Catalog # 902-MP)
4-Aminophenylmercuric acetate (APMA) (Sigma, Catalog # A-9563), 100 mM stock in DMSO
Substrate: MCA-Pro-Leu-Gly-Leu-DPA-Ala-Arg-NH2 (Catalog # ES001) , 2 mM stock in DMSO
F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
Fluorescent Plate Reader (Model: SpectraMax Gemini EM by Molecular Devices) or equivalent
Dilute rhMMP-2 to 100 µg/mL with 1 mM APMA in Assay Buffer.
Incubate at 37 ºC for 1 hour (to activate).
Prepare a curve of rhTIMP-4 (MW: 22,400 Da) in Assay Buffer. Make serial dilutions of: 5000, 2000, 1000, 500, 300, 200, 150, 100, 20, and 2 nM.
After activation, dilute 100 µg/mL rhMMP-2 to 12.5 µg/mL in Assay Buffer.
Mix 16 µL of rhTIMP-4 curve dilutions, 25.6 µL of diluted rhMMP-2, and 118.4 µL of Assay Buffer. Include a control (in duplicate) containing 134.4 µL of Assay Buffer and 25.6 µL of diluted rhMMP-2.
Incubate reactions for 2 hours at 37 °C.
After incubation, dilute the mixtures five fold in Assay Buffer.
Dilute Substrate to 10 µM in Assay Buffer.
Load 50 µL of the diluted incubated mixtures in a plate, and start the reaction by adding 50 µL of 10 µM Substrate.
Read at excitation and emission wavelengths of 320 nm and 405 nm (top read), respectively in kinetic mode for 5 minutes.
Derive the 50% inhibiting concentration (IC50) for rhTIMP-4 by plotting RFU/min (or specific activity) vs. concentration with 4-PL fitting.
The specific activity for rhMMP-2 at each point may be determined using the following formula (if needed):
Specific Activity (pmol/min/µg) =
Adjusted Vmax* (RFU/min) x Conversion Factor** (pmol/RFU)
amount of enzyme (µg)
*Adjusted for Substrate Blank
**Derived using calibration standard MCA-Pro-Leu-OH (Bachem, Catalog # M-1975).
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Recombinant Human TIMP-4 (Sf 21-expressed) Protein, CF
metalloproteinase inhibitor 4
TIMP metallopeptidase inhibitor 4
TIMP4
TIMP-4
tissue inhibitor of metalloproteinase 4
Tissue inhibitor of metalloproteinases 4
Background
Tissue inhibitors of metalloproteinases (TIMPs) are a family of secreted proteins that regulate the activation and proteolytic activity of the zinc enzymes known as matrix metalloproteinases (MMPs). There are four known members of the family, TIMP-1, -2, -3 and -4. TIMP-4 is produced by a wide range of tissues, particularly brain, heart, ovary and skeletal muscle (1, 2). Limited studies have shown that TIMP-4 has a tumor suppressive effect against Wilm’s tumor, exhibits negative correlation with glioma maligancy and is found in breast carcinoma cells (3-5). TIMP-4 inhibits MMP-mediated proteolysis by forming a non-covalent binary complex with the MMP active site through its N-terminal domain. In addition, it binds to the hemopexin-like domain of pro-MMP-2 through its C-terminal domain in a manner similar to TIMP-2 (6). However, unlike TIMP-2, TIMP-4 does not promote pro-MMP-2 activation by MT1-MMP (MMP-14) (7). Although TIMP-4 is a potent inhibitor of most MMPs, it is not an effective inhibitor of ADAMs, such as TACE (8, 9).
Greene, et al. (1996) J. Biol. Chem. 271:30375.
Leco, et al. (1997) FEBS Lett. 401:213.
Geliker, et al. (2001) Oncogene 20:4337.
Groft, et al. (2001) Br. J. Cancer 85:55.
Hurst, et al. (2001) Biochem. Biophys. Res. Comm. 281:166.
Bigg, et al. (1997) J. Biol. Chem. 272:15496.
Hernandez-Barrantes, et al. (2001) Biochem. Biophys. Res. Comm. 281:126.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
=
÷
Review this Product
Be the first to review our Recombinant Human TIMP-4 (Sf 21-expressed) Protein, CF and receive a gift card or discount.